Hockett Claire, Mayfield Laura M, Gill Corey S, Kim Harry K W, Sucato Daniel J, Podeszwa David A, Jo Chan-Hee, Morris William Z
Department of Orthopaedic Surgery, Scottish Rite for Children.
Department of Orthopaedic Surgery, University of Texas, Southwestern Medical Center, Dallas, TX.
J Pediatr Orthop. 2024 Jan 1;44(1):e25-e29. doi: 10.1097/BPO.0000000000002540. Epub 2023 Sep 29.
An initial screening ultrasound is essential for patients at higher risk of developmental dysplasia of the hip (DDH) due to breech presentation or a family history of DDH. The American Academy of Pediatrics recommends screening ultrasounds to be performed after 6 weeks of age to reduce the rate of false positives. However, there is limited evidence regarding whether these screening ultrasounds need to be adjusted for gestational age in prematurity. The purpose of this study was to evaluate the influence of moderate preterm and near-term births on screening hip ultrasounds for high-risk DDH populations.
We identified all prospectively enrolled patients in a single-center database referred for screening hip ultrasound for DDH. We included those hips referred for risk factors of DDH, including breech presentation, family history of DDH, or hip click, and excluded those with known dysplasia or referral for hip instability. Each ultrasound was measured by a pediatric radiologist to determine the alpha angle and femoral head coverage. Patients were classified as "premature" if born at <37 weeks gestation or "full term" if born at ≥37 weeks gestation. All patients underwent screening hip ultrasound between 5 and 8 weeks of age. Sonographic markers of dysplasia and the incidences of abnormal ultrasound and Pavlik harness treatment were compared between cohorts. Significance was set at P <0.05.
A total of 244 hips in 122 patients were included, 58 hips in the premature cohort and 186 hips in the full-term cohort. The premature cohort had a significantly decreased gestational age compared with the full-term cohort (35.4 ± 1.1 vs 38.5 ± 1.1 wk, respectively, P < 0.001). However, there was no difference between premature and full-term cohorts in sex distribution (69% vs 75%, females, P = 0.39), unadjusted age at the time of ultrasound (6.6 ± 0.7 vs 6.8±0.7 wk, respectively, P = 0.07), or referral reason ( P = 0.14). On hip ultrasound, there was no difference between premature and full-term cohorts with respect to alpha angle (62.6 ± 3.3 vs 62.2 ± 5.3 degrees, P = 0.41), femoral head coverage (54.9 ± 6.3 vs 55.1 ± 10.6, P = 0.19), rate of abnormal ultrasound (18.3% vs 20.7%, respectively, P = 0.68), or the rate of Pavlik harness treatment (0% vs 5.3%, respectively, P = 0.12).
There was no significant difference in alpha angle or femoral head coverage between premature and full-term patients at 5 to 8 weeks of unadjusted age. This preliminary data suggests that screening ultrasounds can be performed without adjusting for prematurity.
Level II, prognostic study.
对于因臀位或髋关节发育不良(DDH)家族史而具有较高DDH风险的患者,初始筛查超声检查至关重要。美国儿科学会建议在6周龄后进行筛查超声检查,以降低假阳性率。然而,关于这些筛查超声检查是否需要根据早产的孕周进行调整,证据有限。本研究的目的是评估中度早产和近足月出生对高危DDH人群髋关节筛查超声检查的影响。
我们在一个单中心数据库中识别了所有前瞻性登记的因DDH而接受髋关节筛查超声检查的患者。我们纳入了那些因DDH风险因素而转诊的髋关节,包括臀位、DDH家族史或髋关节弹响,并排除了那些已知发育异常或因髋关节不稳定而转诊的患者。每次超声检查均由儿科放射科医生进行测量,以确定α角和股骨头覆盖率。如果患者在妊娠<37周时出生,则分类为“早产”;如果在妊娠≥37周时出生,则分类为“足月”。所有患者在5至8周龄时接受髋关节筛查超声检查。比较两组之间发育异常的超声标志物、异常超声发生率和帕夫利克吊带治疗发生率。显著性设定为P<0.05。
共纳入122例患者的244个髋关节,早产队列中有58个髋关节,足月队列中有186个髋关节。与足月队列相比,早产队列的孕周显著降低(分别为35.4±1.1周和38.5±1.1周,P<0.001)。然而,早产和足月队列在性别分布(女性分别为69%和75%,P=0.39)、超声检查时未调整的年龄(分别为6.6±0.7周和6.8±0.7周,P=0.07)或转诊原因(P=0.14)方面没有差异。在髋关节超声检查中,早产和足月队列在α角(62.6±3.3度对62.2±5.3度,P=0.41)、股骨头覆盖率(54.9±6.3对55.1±10.6,P=0.19)、异常超声发生率(分别为18.3%和20.7%,P=0.68)或帕夫利克吊带治疗发生率(分别为0%和5.3%,P=0.12)方面没有差异。
在未调整年龄的5至8周时,早产和足月患者的α角或股骨头覆盖率没有显著差异。这些初步数据表明,筛查超声检查可以不根据早产情况进行调整。
二级,预后研究。